Lymphoma (Hodgkin and Non-Hodgkin)




Table of Contents

Lymphoma is a malignant neoplasm of the lymphoid tissue and represents one of the most common hematologic malignancies affecting the head and neck region. Because lymphomas frequently present in cervical lymph nodes, Waldeyer’s ring, and oral soft tissues, dental professionals play a critical role in early detection. Oral lymphomas may mimic inflammatory, infectious, or reactive conditions, leading to diagnostic delay.


Overview and Classification

Lymphomas are broadly classified into:

- Hodgkin Lymphoma (HL)
- Non-Hodgkin Lymphoma (NHL)

The distinction is based on histopathologic and immunophenotypic features, particularly the presence or absence of Reed–Sternberg cells.


Epidemiology and Etiology

General

- Lymphoma is the second most common malignancy of the head and neck after squamous cell carcinoma
- Can occur at any age
- Etiology involves genetic, immunologic, and infectious factors

Risk Factors

- Immunosuppression (HIV/AIDS, transplant patients)
- Autoimmune diseases
- Epstein–Barr virus (EBV) infection
- Helicobacter pylori (gastric MALT lymphoma)
- Environmental exposures


Hodgkin Lymphoma (HL)

Definition and Pathogenesis

Hodgkin lymphoma is a B-cell malignancy characterized by the presence of Reed–Sternberg (RS) cells, which are large atypical lymphoid cells with bilobed nuclei and prominent nucleoli.

Epidemiology

- Bimodal age distribution (young adults and older adults)
- Slight male predominance
- Oral involvement is rare

Common Sites

- Cervical lymph nodes
- Mediastinum
- Waldeyer’s ring (rare oral involvement)

Clinical Features

- Painless lymphadenopathy
- “B symptoms”: fever, night sweats, weight loss
- Fatigue and pruritus
- Oral lesions are uncommon and usually secondary

Histopathology

- Presence of Reed–Sternberg cells
- Mixed inflammatory background
- Subtypes include:

   = Nodular sclerosis
   = Mixed cellularity
   = Lymphocyte-rich
   = Lymphocyte-depleted

Immunohistochemistry

- RS cells: CD15 positive, CD30 positive
- Negative for CD45

Prognosis

- Generally favorable
- High cure rates with modern therapy


Non-Hodgkin Lymphoma (NHL)

Definition and Pathogenesis

Non-Hodgkin lymphoma comprises a heterogeneous group of lymphoid malignancies derived from B cells, T cells, or NK cells. NHL is far more likely than HL to involve extranodal sites, including the oral cavity.

Epidemiology

- More common than HL
- Incidence increases with age
- Strong association with immunosuppression

Common Oral and Maxillofacial Sites

- Waldeyer’s ring (tonsils, base of tongue)
- Palate
- Gingiva
- Buccal mucosa
- Jaw bones (rare but important)

Clinical Presentation

- Non-tender, firm swelling
- Ulceration or mucosal erythema
- Tooth mobility or non-healing extraction sockets
- Paresthesia (“numb chin syndrome”)
- Cervical lymphadenopathy

Oral NHL often mimics periodontal disease or odontogenic infection.

Common Oral NHL Subtypes

- Diffuse large B-cell lymphoma (DLBCL) – most common
- Extranodal marginal zone lymphoma (MALT lymphoma)
- Burkitt lymphoma (especially in children)
- Peripheral T-cell lymphoma (rare but aggressive)

Pathology

Histopathological Features

- Diffuse or nodular proliferation of atypical lymphoid cells
- Loss of normal lymph node architecture
- High mitotic activity in aggressive types

Immunohistochemistry

Used to confirm lineage and subtype:

- B-cell markers: CD20, CD79a
- T-cell markers: CD3
- Ki-67 proliferation index helps determine aggressiveness


Imaging Characteristics

- Radiographs may show ill-defined radiolucency in jaw lesions
- CT and MRI demonstrate soft tissue mass and bone involvement
- PET-CT used for staging and treatment monitoring


Diagnosis

Definitive diagnosis requires:

- Incisional or excisional biopsy
- Histopathologic examination
- Immunophenotyping
- Systemic staging

Fine-needle aspiration alone is usually insufficient.


Treatment Principles

Hodgkin Lymphoma

- Combination chemotherapy
- Radiotherapy in selected cases
- Excellent response rates

Non-Hodgkin Lymphoma

- Treatment depends on subtype and stage
- Chemotherapy ± immunotherapy (e.g., rituximab)
- Radiotherapy for localized disease
- Surgery is not primary treatment


Prognostic Factors

- Lymphoma subtype
- Disease stage
- Patient age and immune status
- Tumor proliferation index
- Response to therapy

HL generally has a better prognosis than aggressive NHL.


Role of Dental Professionals

Dental professionals are critical in early recognition:

- Investigate unexplained oral swellings or ulcerations
- Be alert to rapid tissue enlargement without infection
- Biopsy suspicious lesions promptly
- Manage oral complications of chemotherapy and radiotherapy
- Provide long-term oral care and surveillance


Conclusion

Lymphoma is a significant malignancy with frequent head and neck involvement. Non-Hodgkin lymphoma, in particular, often presents in the oral cavity and may mimic common dental conditions. Early detection by dental professionals, combined with prompt biopsy and referral, plays a vital role in improving patient outcomes.

Report aproblem
Previous Post Next Post
Update cookies preferences